Aclid is the security and safety platform for synthetic biology co-founded by Professor Harris Wang from Columbia University. The company's DNA screening solution for biosecurity, export control compliance, and EH&S keeps researchers safe and protects national security.
Location: United States, New York
Employees: 1-10
Total raised: $3.3M
Investors 1
| Date | Name | Website |
| 12.12.2021 | 2048 Ventu... | 2048.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.10.2023 | Seed | $3.3M | - |
Mentions in press and media 2
| Date | Title | Description |
| 12.10.2023 | Aclid Closes $3.3M Seed Funding Round | Aclid, a NYC-based provider of a security and compliance automation platform for the biotechnology industry, raised $3.3M in Seed funding. The round was led by 2048 Ventures and IA Ventures. The company intends to use the funds to meet cust... |
| 12.10.2023 | Aclid Raises $3.3M Oversubscribed Seed Round | NEW YORK, NY, Aclid, the security and compliance automation platform for the biotechnology industry, today announced it closed an oversubscribed seed financing of $3.3 million. >> Click here for more funding data on Aclid >>... |